Haoxi Health Technology Ltd.
13F holders, Q4 2024 (December 31)7holders −3
5new positions
8sold out
$0.15avg. 13F price*
At the end of Q4 2024, 7 institutions reported holding Haoxi Health Technology Ltd. in their 13F filings, down 3 from Q3 2024. 5 opened new positions and 8 sold out. The largest holders were Meteora Capital, LLC ($255K), UBS Group AG ($49K) and DGS Capital Management, LLC ($6K).
- Company
- Haoxi Health Technology Ltd.
- CUSIP
- G4290F100
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $15K |
| Exits | 8 | $295K |
All 13F filers, Q3 2024 → Q4 2024: 1,558,573 shares bought and 819,411 shares sold, net +739,162 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Meteora Capital, LLC | 0.09% | Add +249.0% | 1,699,253 | $255K |
| UBS Group AG | 0.00% | Add +315.7% | 328,035 | $49K |
| DGS Capital Management, LLC | 0.00% | New | 38,344 | $6K |
| Two Sigma Investments, LP | 0.00% | New | 27,382 | $4K |
| Two Sigma Securities, LLC | 0.00% | New | 21,323 | $3K |
| Sassicaia Capital Advisers LLC | 0.04% | New | 10,000 | $2K |
| Bank of America Corp. | 0.00% | New | 100 | $15 |
"% of holder's portfolio" is HAOXI HEALTH TECHNOLOGY LTD's weight in each manager's 13F, not the share of Haoxi Health Technology Ltd. the manager owns.